Carmell Therapeutics Corporation – NASDAQ:CTCX

Carmell Therapeutics stock price today

$0.203
-0.10
-33.71%
Financial Health
0
1
2
3
4
5
6
7
8
9

Carmell Therapeutics stock price monthly change

-83.28%
month

Carmell Therapeutics stock price quarterly change

-83.28%
quarter

Carmell Therapeutics stock price yearly change

-92.21%
year

Carmell Therapeutics key metrics

Market Cap
 4.69M
Enterprise value
 N/A
P/E
 N/A
EV/Sales
 N/A
EV/EBITDA
 N/A
Price/Sales
 N/A
Price/Book
 N/A
PEG ratio
 N/A
EPS
 -0.52
Revenue
 N/A
EBITDA
 -6.69M
Income
 -12.79M
Revenue Q/Q
 N/A
Revenue Y/Y
 N/A
Profit margin
 0%
Oper. margin
 0%
Gross margin
 0%
EBIT margin
 0%
EBITDA margin
 N/A

Get more financial ratios!

  • Every financial ratio you might need

  • 10 years history

  • Forward ratios (Analysts estimates)

Sign up &
create your own Smart Feed

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Sign up for free

Carmell Therapeutics stock price history

Carmell Therapeutics stock forecast

Carmell Therapeutics financial statements

Profit Margin

Carmell Therapeutics Corporation (NASDAQ:CTCX): Profit margin
Jun 2023 0 317.51K
Sep 2023 3.72M -11.46M -307.46%
Dec 2023 -3.72M 3.15M -84.67%
Mar 2024 0 -4.80M
CTCX income statement history

Debt to Assets

Carmell Therapeutics Corporation (NASDAQ:CTCX): Debt to assets
Jun 2023 160300925 4.11M 2.56%
Sep 2023 82223945 61.30M 74.56%
Dec 2023 63948803 39.19M 61.3%
Mar 2024 6180343 7.57M 122.52%
CTCX balance sheet history

Cash Flow

Carmell Therapeutics Corporation (NASDAQ:CTCX): Cash Flow
Jun 2023 -5.88K 0 -375K
Sep 2023 -5.02M 632.52K 12.41M
Dec 2023 -3.14M -662.99K -1.24M
Mar 2024 -1.07M -748.79K -195.72K
CTCX cash flow history

Carmell Therapeutics alternative data

Carmell Therapeutics
Employees

Carmell Therapeutics Corporation (NASDAQ:CTCX): Employee count
Dec 2023 10
Jan 2024 14
Feb 2024 14
Mar 2024 14
Apr 2024 14
May 2024 9
Jun 2024 9
Jul 2024 9

Carmell Therapeutics other data

Carmell Therapeutics
Insider Trading

Carmell Therapeutics Corporation (NASDAQ:CTCX): Insider trades (number of shares)
Period Buy Sel
Apr 2024 8680 0
May 2024 13172 0
Jun 2024 4540 0
Transaction Date Insider Security Shares Price per share Total value Source
Purchase
UPTON RICHARD A director
 Common Stock 2,000 $2.21 $4,410
Purchase
CASSADAY BRYAN J. officer: Chief Financial Officer
 Common Stock 440 $2.5 $1,100
Purchase
SHUKLA RAJIV director, 10 perc.. Common Stock 2,100 $2.63 $5,527
Purchase
CASSADAY BRYAN J. officer: Chief Financial Officer
 Common Stock 365 $2.55 $931
Purchase
SHUKLA RAJIV director, 10 perc.. Common Stock 2,000 $2.5 $5,000
Purchase
CASSADAY BRYAN J. officer: Chief Financial Officer
 Common Stock 30 $2.6 $78
Purchase
SHUKLA RAJIV director, 10 perc.. Common Stock 1,939 $2.57 $4,991
Purchase
SHUKLA RAJIV director, 10 perc.. Common Stock 2,100 $2.5 $5,250
Purchase
SHUKLA RAJIV director, 10 perc.. Common Stock 4,051 $2.41 $9,771
Purchase
SHUKLA RAJIV director, 10 perc.. Common Stock 1,515 $2.39 $3,616
CTCX insider trading transactions

Frequently Asked Questions (FAQ)

  • What's the price of Carmell Therapeutics stock today?

    One share of Carmell Therapeutics stock can currently be purchased for approximately $0.2.

  • When is Carmell Therapeutics's next earnings date?

    Unfortunately, Carmell Therapeutics's (CTCX) next earnings date is currently unknown.

  • Does Carmell Therapeutics pay dividends?

    No, Carmell Therapeutics does not pay dividends.

  • How much money does Carmell Therapeutics make?

    Carmell Therapeutics has a market capitalization of 4.69M.

  • What is Carmell Therapeutics's stock symbol?

    Carmell Therapeutics Corporation is traded on the NASDAQ under the ticker symbol "CTCX".

  • What is Carmell Therapeutics's primary industry?

    Company operates in the Healthcare sector and Biotechnology industry.

  • How do i buy shares of Carmell Therapeutics?

    Shares of Carmell Therapeutics can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

  • How many employees does Carmell Therapeutics have?

    As Jul 2024, Carmell Therapeutics employs 9 workers, which is 36% less then previous quarter.

  • When Carmell Therapeutics went public?

    Carmell Therapeutics Corporation is publicly traded company for more then 4 years since IPO on 23 Sep 2021.

  • What is Carmell Therapeutics's official website?

    The official website for Carmell Therapeutics is carmellrx.com.

  • Where are Carmell Therapeutics's headquarters?

    Carmell Therapeutics is headquartered at 2403 Sidney Street, Pittsburgh, PA.

  • How can i contact Carmell Therapeutics?

    Carmell Therapeutics's mailing address is 2403 Sidney Street, Pittsburgh, PA and company can be reached via phone at +41 28948248.

Carmell Therapeutics company profile:

Carmell Therapeutics Corporation

carmellrx.com
Exchange:

NASDAQ

Full time employees:

9

Industry:

Biotechnology

Sector:

Healthcare

Carmell Therapeutics Corporation focuses on the development of plasma-based bioactive material (PBM) to stimulate tissue repair or growth after injury, disease, and aging. Its lead product candidate is CT-101 bone healing accelerant for tibia fracture healing, foot/ankle fusion, spinal fusion, dental bone graft substitute, and bone void filler; and tissue healing accelerant for androgenetic alopecia and chronic wound healing. The company was founded in 2008 and is based in Pittsburgh, Pennsylvania.

+41 28948248
2403 Sidney Street
Pittsburgh, PA 15203

CIK: 0001842939
ISIN: US1429221039
CUSIP: 142922103